FIELD: veterinary.
SUBSTANCE: invention is used for inflammatory organs containing liquid and natural external opening, for example diary animal udder or hearing apparatus. Method includes introduction of pharmaceutical composition containing effective amount of antiphlogistic agent. In addition, the above composition contains (a) amphiphile oil, which is water-soluble and ethanol insoluble, (b) microcristalline paraffine and (c) nonaqueous component which is pharmaceutically suitable.
EFFECT: easily dissolved in liquid contained in organ.
15 cl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DISPERSIBLE PREPARATION OF ANTIINFLAMMATION AGENT | 2004 |
|
RU2319508C2 |
| DISPERSIBLE PHARMACEUTICAL COMPOSITIONS | 2003 |
|
RU2311201C2 |
| DISPERSIBLE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF MASTITIS AND OTIC DISORDERS | 2004 |
|
RU2321423C2 |
| SOLUBLE PHARMACEUTICAL COMPOSITION FOR MASTITIS AND EAR INVOLVEMENT TREATMENT | 2004 |
|
RU2329064C2 |
| LYSOBACTIN FOR USE IN TREATMENT OF BOVINE MASTITIS | 2016 |
|
RU2741764C2 |
| FINAFLOXACIN-INCLUDING COMPOSITIONS, AND METHODS OF TREATING OPHTHALMOLOGICAL, AURAL AND NASAL INFECTIONS | 2010 |
|
RU2570731C2 |
| ANTI-INFLAMMATORY AND ANTI-ALLERGIC MEDICATION AND BASED ON IT PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2426540C1 |
| METHOD AND COMPOSITION FOR OTITIS EXTERNA TREATMENT | 2010 |
|
RU2680137C2 |
| COMBINATIONS OF LYSOBACTIN AND AMINOGLYCOSIDES AGAINST DISEASES CAUSED BY GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA IN NON-HUMAN ANIMALS | 2018 |
|
RU2760008C2 |
| METHODS OF TREATING MICROBIAL INFECTIONS, INCLUDING MASTITIS | 2014 |
|
RU2662300C2 |
